|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
D
|
|
INDICATIONS:
|
|
Carcinoma, lung |
|
Carcinoma, testicular |
| |
|
|
SIDE EFFECTS:
|
|
Anemia |
|
leukopenia |
|
thrombocytopenia |
|
Stomatitis |
|
Anaphylaxis |
|
chemical phlebitis |
|
neurotoxicity |
|
skin rash or itching |
|
Loss of appetite |
|
nausea and vomiting |
|
Central nervous system (CNS) toxicity |
|
diarrhea |
|
Alopecia |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
>> Bone marrow depression |
|
>> Chickenpox, existing |
|
>> Herpes zoster |
|
Hepatic function impairment |
|
>> Infection |
|
Renal function impairment |
|
Sensitivity to etoposide |
|
|
ADULT DOSE:
|
|
Germ cell testicular tumors-Intravenous infusion, 50 to 100 mg (base) per square meter of body surface area per day on days 1 through 5 to 100 mg per square meter of body surface area on days 1, 3, and 5 of a regimen that is repeated every three to four weeks .
Small cell lung carcinoma-Intravenous infusion, 35 mg (base) per square meter of body surface area per day for four days to 50 mg per square meter of body surface area per day for five days, repeated every three to four weeks.
[Lymphomas, Hodgkin's] or
[Lymphomas, non-Hodgkin's]or
[Lymphomas, cutaneous T-cell ] or
[Leukemia, acute nonlymphocytic] or
[Leukemia, acute lymphocytic] or
[Multiple myeloma] or
[Ewing's sarcoma] or
[Kaposi's sarcoma, autoimmune deficiency syndrome (AIDS)-associated] or
[Sarcomas, soft tissue] or
[Osteosarcoma ] or
[ Carcinoma, adrenocortical] or
[Carcinoma, gastric] or
[Carcinoma, lung, non-small cell] or
[ Carcinoma, endometrial] or
[Hepatoblastoma] or
[Neuroblastoma ] or
[ Retinoblastoma ] or
[Thymoma] or
[Wilms" tumor] or
[Tumors, brain, primary] or
[Tumors, trophoblastic, gestational] or
[Tumors, germ cell, ovarian] -Consult medical literature and manufacturer's literature for specific dosage. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Dosage has not been established.
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|